Veterinary CRO Market by Service Type (Clinical Trials, Toxicology, Market Authorization & Regulatory Support, and Others), Application (Dogs, Cats, and Others), and End User (Oncology, Infectious Diseases, Neurology, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

Contract research organizations (CROs) are companies that help assist in research & development and/or other services related to newer products for sponsor companies. Sponsors frequently outsource their product development functions to independent service providers to augment their practice of a flexible cost structure and overcome the requirement to maintain redundant development proficiencies globally. Clinical, regulatory, and therapeutic expertise of CROs help improvise total cost of product development and market entry of a new product. As a result, CROs have emerged as competent providers of an increasing array of value-added services for veterinary companies and are expected to continue to play a vital role in the in vivo studies involving companion animals. Furthermore, veterinary CROs support sponsor companies by providing assistance in veterinary clinical trial development, strategic regulatory affairs expertise, project management support for an extensive range of veterinary products, new product development, lifecycle management of existing marketing authorizations (MA), and veterinary good clinical practice (GCP) regulatory management. Veterinary CROs also offer services such as strategic advice on data management & statistical analysis, post-marketing support, gap analysis, as well as pharmacovigilance. These services are often used by veterinary researchers and medicine manufacturers for newer product development along with testing safety & efficacy of veterinary drugs.

Accordingly, the global veterinary CRO market is poised to reach $1,260.5 million in 2027 from $771.8 million in 2019, and is expected to register a CAGR of 7.7% during the forecast period.

The growth rate is majorly attributed to surge in ownership of companion animals and rise in animal health expenditure. Furthermore, other factors such as increase in global prevalence of diseases among companion animals and surge in the R&D activities among veterinary medicine manufacturers act as key development factors that contribute toward growth of the market. Nevertheless, lack of standardization in veterinary CROs is anticipated to hinder the market growth. Conversely, awareness associated with animal healthcare is on the rise as pet owners are more concerned about health and diseases of their companion animals. This increase in awareness related to animal healthcare across the globe is expected to provide profitable opportunities for key industry players in the market during the forecast period. Furthermore, presence of associations and NGOs that work toward spreading awareness related to animal healthcare are predicted to expose newer possibilities for growth of veterinary CROs market.

On the other hand, COVID-19 pandemic has greatly disrupted ongoing activities in the veterinary sector. Cost constraints on the entire animal healthcare industry, owing to economic slowdown due to the pandemic has imposed limitations on R&D finances of veterinary companies and has led companies to outsource these activities to veterinary CROs, consequently supplementing the market growth. Moreover, susceptibility of domesticated animals to SARS-CoV-2 along with reported cases in cats and dogs have raised concerns regarding the infection to emerge as a disease in animals in coming years. Accordingly, there is a substantial increase in R&D activities for development of COVID-19 veterinary vaccines and antiviral drugs. This has immensely heightened demand for companion animals such as cats for research purposes. Several clinical trials around the globe are currently investigated, which drives demand for such animals.

The research study segments the global veterinary CRO market into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, it is classified into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (the U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, the UK, and rest of Europe), Asia-Pacific (Japan, China, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

ü This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2027, which assists to identify the prevailing market opportunities.

ü An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

ü A comprehensive analysis of the factors that drive and restrain the growth of the global Veterinary CRO market is provided.

ü An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO perspective

3.1.Market definition and scope

3.1.1.Top impacting factors

3.1.2.Top investment pockets

3.2.Key forces shaping veterinary CRO industry/ market

3.2.1.Bargaining power of buyers

3.2.2.Bargaining power of suppliers

3.2.3.Threat of new entrants

3.2.4.Threat of substitutes

3.2.5.Intensity of competitive rivalry

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Surge in ownership of companion animals

3.3.1.2.Rise in animal health expenditure

3.3.1.3.Increase in prevalence of diseases among companion animals

3.3.2.Restraint

3.3.2.1.Lack of standardization in veterinary CROs

3.3.3.Opportunity

3.3.3.1.Surge in awareness related to animal healthcare

3.3.4.Impact Analysis

3.4.COVID-19 Impact analysis on the market

4.1.Overview

4.1.1.Market size and forecast

4.2.Clinical trials

4.2.1.Key market trends and growth opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.3.Toxicology

4.3.1.Key market trends and growth opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market analysis, by country

4.4.Market authorization and regulatory support

4.4.1.Key market trends and growth opportunities

4.4.2.Market size and forecast, by region

4.4.3.Market analysis, by country

4.5.Others

4.5.1.Key market trends and growth opportunities

4.5.2.Market size and forecast, by region

4.5.3.Market analysis, by country

5.1.Overview

5.1.1.Market size and forecast

5.2.Dogs

5.2.1.Market size and forecast, by region

5.2.2.Market analysis, by country

5.3.Cats

5.3.1.Market size and forecast, by region

5.3.2.Market analysis, by country

5.4.Others

5.4.1.Market size and forecast, by region

5.4.2.Market analysis, by country

6.1.Overview

6.1.1.Market size and forecast

6.2.Oncology

6.2.1.Market size and forecast, by region

6.2.2.Market analysis, by country

6.3.Infectious disease

6.3.1.Market size and forecast, by region

6.3.2.Market analysis, by country

6.4.Neurology

6.4.1.Market size and forecast, by region

6.4.2.Market analysis, by country

6.5.Others

6.5.1.Market size and forecast, by region

6.5.2.Market analysis, by country

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities

7.2.2.North America market size and forecast, by service type

7.2.3.North America market size and forecast, by animal type

7.2.4.North America market size and forecast, by indication

7.2.5.Market analysis by country

7.2.5.1.U.S.

7.2.5.1.1.U.S. market size and forecast, by service type

7.2.5.1.2.U.S. market size and forecast, by animal type

7.2.5.1.3.U.S. market size and forecast, by indication

7.2.5.2.Canada

7.2.5.2.1.Canada market size and forecast, by service type

7.2.5.2.2.Canada market size and forecast, by animal type

7.2.5.2.3.Canada market size and forecast, by indication

7.2.5.3.Mexico

7.2.5.3.1.Mexico market size and forecast, by service type

7.2.5.3.2.Mexico market size and forecast, by animal type

7.2.5.3.3.Mexico market size and forecast, by indication

7.3.Europe

7.3.1.Key market trends and opportunities

7.3.2.Europe market size and forecast, by service type

7.3.3.Europe market size and forecast, by animal type

7.3.4.Europe market size and forecast, by indication

7.3.5.Market analysis by country

7.3.5.1.Germany

7.3.5.1.1.Germany market size and forecast, by service type

7.3.5.1.2.Germany market size and forecast, by animal type

7.3.5.1.3.Germany market size and forecast, by indication

7.3.5.2.France

7.3.5.2.1.France market size and forecast, by service type

7.3.5.2.2.France market size and forecast, by animal type

7.3.5.2.3.France market size and forecast, by indication

7.3.5.3.UK

7.3.5.3.1.UK market size and forecast, by service type

7.3.5.3.2.UK market size and forecast, by animal type

7.3.5.3.3.UK market size and forecast, by indication

7.3.5.4.Italy

7.3.5.4.1.Italy market size and forecast, by service type

7.3.5.4.2.Italy market size and forecast, by animal type

7.3.5.4.3.Italy market size and forecast, by indication

7.3.5.5.Spain

7.3.5.5.1.Spain market size and forecast, by service type

7.3.5.5.2.Spain market size and forecast, by animal type

7.3.5.5.3.Spain market size and forecast, by indication

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe market size and forecast, by service type

7.3.5.6.2.Rest of Europe market size and forecast, by animal type

7.3.5.6.3.Rest of Europe market size and forecast, by indication

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities

7.4.2.Asia-Pacific market size and forecast, by service type

7.4.3.Asia-Pacific market size and forecast, by animal type

7.4.4.Asia-Pacific market size and forecast, by indication

7.4.5.Market analysis by country

7.4.5.1.Japan

7.4.5.1.1.Japan market size and forecast, by service type

7.4.5.1.2.Japan market size and forecast, by animal type

7.4.5.1.3.Japan market size and forecast, by indication

7.4.5.2.China

7.4.5.2.1.China market size and forecast, by service type

7.4.5.2.2.China market size and forecast, by animal type

7.4.5.2.3.China market size and forecast, by indication

7.4.5.3.Australia

7.4.5.3.1.Australia market size and forecast, by service type

7.4.5.3.2.Australia market size and forecast, by animal type

7.4.5.3.3.Australia market size and forecast, by indication

7.4.5.4.Rest of Asia-Pacific

7.4.5.4.1.Rest of Asia-Pacific market size and forecast, by service type

7.4.5.4.2.Rest of Asia-Pacific market size and forecast, by animal type

7.4.5.4.3.Rest of Asia-Pacific market size and forecast, by indication

7.5.LAMEA

7.5.1.Key market trends and opportunities

7.5.2.LAMEA market size and forecast, by service type

7.5.3.LAMEA market size and forecast, by animal type

7.5.4.LAMEA market size and forecast, by indication

7.5.5.Market analysis by country

7.5.5.1.Brazil

7.5.5.1.1.Brazil market size and forecast, by service type

7.5.5.1.2.Brazil market size and forecast, by animal type

7.5.5.1.3.Brazil market size and forecast, by indication

7.5.5.2.South Africa

7.5.5.2.1.South Africa market size and forecast, by service type

7.5.5.2.2.South Africa market size and forecast, by animal type

7.5.5.2.3.South Africa market size and forecast, by indication

7.5.5.3.Saudi Arabia

7.5.5.3.1.Saudi Arabia market size and forecast, by service type

7.5.5.3.2.Saudi Arabia market size and forecast, by animal type

7.5.5.3.3.Saudi Arabia market size and forecast, by indication

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Rest of LAMEA market size and forecast, by service type

7.5.5.4.2.Rest of LAMEA market size and forecast, by animal type

7.5.5.4.3.Rest of LAMEA market size and forecast, by indication

8.1.Introduction

8.1.1.Market player positioning, 2019

8.2.Top winning strategies and key developments

8.3.Competitive dashboard

8.4.Competitive heatmap

9.1.CHARLES RIVER LABORATORIES, INC.

9.1.1.Company overview

9.1.2.Company snapshot

9.1.3.Operating business segments

9.1.4.Service portfolio

9.1.5.Business performance

9.1.6.Key strategic moves and developments

9.2.CLINVET

9.2.1.Company overview

9.2.2.Company snapshot

9.2.3.Operating business segments

9.2.4.Service portfolio

9.3.KLIFOVET AG

9.3.1.Company overview

9.3.2.Company snapshot

9.3.3.Operating business segments

9.3.4.Service portfolio

9.4.LÖHLEIN & WOLF VET RESEARCH

9.4.1.Company overview

9.4.2.Company snapshot

9.4.3.Operating business segments

9.4.4.Service portfolio

9.5.ONCOVET CLINICAL RESEARCH

9.5.1.Company overview

9.5.2.Company snapshot

9.5.3.Operating business segments

9.5.4.Service portfolio

9.6.ONDAX SCIENTIFIC

9.6.1.Company overview

9.6.2.Company snapshot

9.6.3.Operating business segments

9.6.4.Service portfolio

9.7.TRIVERITAS

9.7.1.Company overview

9.7.2.Company snapshot

9.7.3.Operating business segments

9.7.4.Service portfolio

9.8.VETERINARY RESEARCH MANAGEMENT (VRM) LTD

9.8.1.Company overview

9.8.2.Company snapshot

9.8.3.Operating business segments

9.8.4.Service portfolio

9.9.VETPHARM, INC.

9.9.1.Company overview

9.9.2.Company snapshot

9.9.3.Operating business segments

9.9.4.Service portfolio

9.10.VETSPIN SRL

9.10.1.Company overview

9.10.2.Company snapshot

9.10.3.Operating business segments

9.10.4.Service portfoli

LIST OF TABLES

TABLE 01.NUMBER OF U.S. HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (MILLION)

TABLE 02.POPULATION OF DOGS AND CATS IN EUROPEAN COUNTRIES, 2019

TABLE 03.PARASITE DISEASES & THEIR PREVALENCE IN U.S., 2019

TABLE 04.VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 05.VETERINARY CRO MARKET FOR CLINICAL TRIALS, BY REGION, 2019–2027 ($MILLION)

TABLE 06.VETERINARY CRO MARKET FOR TOXICOLOGY SERVICE, BY REGION, 2019–2027 ($MILLION)

TABLE 07.VETERINARY CRO MARKET FOR MARKET AUTHORIZATION AND REGULATORY SUPPORT SERVICE, BY REGION 2019–2027 ($MILLION)

TABLE 08.VETERINARY CRO MARKET FOR OTHER SERVICES, BY REGION, 2019–2027 ($MILLION)

TABLE 09.VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 10.VETERINARY CRO MARKET FOR DOGS, BY REGION, 2019–2027 ($MILLION)

TABLE 11.VETERINARY CRO MARKET FOR CATS, BY REGION, 2019–2027 ($MILLION)

TABLE 12.VETERINARY CRO MARKET FOR OTHER ANIMALS, BY REGION, 2019–2027 ($MILLION)

TABLE 13.VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 14.VETERINARY CRO MARKET FOR ONCOLOGY, BY REGION, 2019–2027 ($MILLION)

TABLE 15.VETERINARY CRO MARKET FOR INFECTIOUS DISEASE, BY REGION, 2019–2027 ($MILLION)

TABLE 16.VETERINARY CRO MARKET FOR NEUROLOGY, BY REGION, 2019–2027 ($MILLION)

TABLE 17.VETERINARY CRO MARKET FOR OTHER INDICATIONS, BY REGION 2019–2027 ($MILLION)

TABLE 18.VETERINARY CRO MARKET, BY REGION, 2019–2027 ($MILLION)

TABLE 19.NORTH AMERICA VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 20.NORTH AMERICA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 21.NORTH AMERICA VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 22.NORTH AMERICA VETERINARY CRO MARKET, BY COUNTRY, 2019–2027 ($MILLION)

TABLE 23.U.S. VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 24.U.S. VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 25.U.S. VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 26.CANADA VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 27.CANADA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 28.CANADA VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 29.MEXICO VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 30.MEXICO VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 31.MEXICO VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 32.EUROPE VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 33.EUROPE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 34.EUROPE VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 35.EUROPE VETERINARY CRO MARKET, BY COUNTRY, 2019–2027 ($MILLION)

TABLE 36.GERMANY VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 37.GERMANY VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 38.GERMANY VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 39.FRANCE VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 40.FRANCE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 41.FRANCE VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 42.UK VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 43.UK VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 44.UK VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 45.ITALY VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 46.ITALY VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 47.ITALY VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 48.SPAIN VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 49.SPAIN VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 50.SPAIN VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 51.REST OF EUROPE VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 52.REST OF EUROPE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 53.REST OF EUROPE VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 54.ASIA-PACIFIC VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 55.ASIA-PACIFIC VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 56.ASIA-PACIFIC VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 57.ASIA-PACIFIC VETERINARY CRO MARKET, BY COUNTRY, 2019–2027 ($MILLION)

TABLE 58.JAPAN VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 59.JAPAN VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 60.JAPAN VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 61.CHINA VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 62.CHINA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 63.CHINA VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 64.AUSTRALIA VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 65.AUSTRALIA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 66.AUSTRALIA VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 67.REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 68.REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 69.REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 70.LAMEA VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 71.LAMEA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 72.LAMEA VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 73.LAMEA VETERINARY CRO MARKET, BY COUNTRY, 2019–2027 ($MILLION)

TABLE 74.BRAZIL VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 75.BRAZIL VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 76.BRAZIL VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 77.SOUTH AFRICA VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 78.SOUTH AFRICA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 79.SOUTH AFRICA VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 80.SAUDI ARABIA VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 81.SAUDI ARABIA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 82.SAUDI ARABIA VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 83.REST OF LAMEA VETERINARY CRO MARKET, BY SERVICE TYPE, 2019–2027 ($MILLION)

TABLE 84.REST OF LAMEA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2019–2027 ($MILLION)

TABLE 85.REST OF LAMEA VETERINARY CRO MARKET, BY INDICATION, 2019–2027 ($MILLION)

TABLE 86.CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT

TABLE 87.CHARLES RIVER LABORATORIES, INC.: OPERATING SEGMENTS

TABLE 88.CHARLES RIVER LABORATORIES, INC. PLC: SERVICE PORTFOLIO

TABLE 89.CLINVET: COMPANY SNAPSHOT

TABLE 90.CLINVET INC.: OPERATING SEGMENTS

TABLE 91.CLINVET INC.: SERVICE PORTFOLIO

TABLE 92.KLIFOVET AG: COMPANY SNAPSHOT

TABLE 93.KLIFOVET AG: OPERATING SEGMENTS

TABLE 94.KLIFOVET AG: SERVICE PORTFOLIO:

TABLE 95.LÖHLEIN & WOLF VET RESEARCH: COMPANY SNAPSHOT

TABLE 96.LÖHLEIN & WOLF VET RESEARCH: OPERATING SEGMENTS

TABLE 97.LÖHLEIN & WOLF VET RESEARCH: SERVICE PORTFOLIO

TABLE 98.ONCOVET CLINICAL RESEARCH: COMPANY SNAPSHOT

TABLE 99.ONCOVET CLINICAL RESEARCH: OPERATING SEGMENTS

TABLE 100.ONCOVET CLINICAL RESEARCH: SERVICE PORTFOLIO

TABLE 101.ONDAX SCIENTIFIC: COMPANY SNAPSHOT

TABLE 102.ONDAX SCIENTIFIC: OPERATING SEGMENTS

TABLE 103.ONDAX SCIENTIFIC: SERVICE PORTFOLIO

TABLE 104.TRIVERITAS: COMPANY SNAPSHOT

TABLE 105.TRIVERITAS: OPERATING SEGMENTS

TABLE 106.TRIVERITAS: SERVICE PORTFOLIO

TABLE 107.VRM: COMPANY SNAPSHOT

TABLE 108.VRM: OPERATING SEGMENTS

TABLE 109.VRM: SERVICE PORTFOLIO

TABLE 110.VETPHARM, INC.: COMPANY SNAPSHOT

TABLE 111.VETPHARM, INC.: BUSINESS SEGMENTS

TABLE 112.VETPHARM, INC.: SERVICE PORTFOLIO

TABLE 113.VETSPIN SRL.: COMPANY SNAPSHOT

TABLE 114.VETSPIN SRL.: OPERATING SEGMENTS

TABLE 115.VETSPIN SRL: SERVICE PORTFOLIO LIST OF FIGURES

FIGURE 01.VETERINARY CRO MARKET: SEGMENTATION

FIGURE 02.TOP IMPACTING FACTORS

FIGURE 03.TOP INVESTMENT POCKETS

FIGURE 04.HIGH BARGAINING POWER OF BUYERS

FIGURE 05.LOW BARGAINING POWER OF SUPPLIERS

FIGURE 06.LOW THREAT OF NEW ENTRANTS

FIGURE 08.HIGH COMPETITIVE RIVALRY

FIGURE 09.U.S. PET INDUSTRY EXPENDITURE, 2010–2019 ($BILLION)

FIGURE 10.IMPACT ANALYSES

FIGURE 11.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR TOXICOLOGY SERVICE, BY COUNTRY, 2019 & 2027 (%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR MARKET AUTHORIZATION AND REGULATORY SUPPORT SERVICE, BY COUNTRY, 2019 & 2027 (%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR OTHER SERVICES, BY COUNTRY, 2019 & 2027 (%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR DOGS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR CATS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR OTHER ANIMALS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR ONCOLOGY, BY COUNTRY, 2019 & 2027 (%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR INFECTIOUS DISEASE, BY COUNTRY, 2019 & 2027 (%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR NEUROLOGY, BY COUNTRY, 2019 & 2027 (%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019 & 2027 (%)

FIGURE 22.U.S. VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 23.CANADA VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 24.MEXICO VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 25.GERMANY VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 26.FRANCE VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 27.UK VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 28.ITALY VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 29.SPAIN VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 30.REST OF EUROPE VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 31.JAPAN VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 32.CHINA VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 33.AUSTRALIA VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 34.REST OF ASIA-PACIFIC VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 35.BRAZIL VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 36.SOUTH AFRICA VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 37.SAUDI ARABIA VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 38.REST OF LAMEA VETERINARY CRO MARKET, 2019–2027 ($MILLION)

FIGURE 39.MARKET PLAYER POSITIONING, 2019

FIGURE 40.COMPETITIVE DASHBOARD

FIGURE 41.COMPETITIVE HEATMAP OF KEY PLAYERS

FIGURE 42.CHARLES RIVER LABORATORIES INC.: NET SALES, 2017–2019 ($MILLION)

FIGURE 43.CHARLES RIVER LABORATORIES INC.: REVENUE SHARE, BY SEGMENT, 2019 (%)

FIGURE 44.CHARLES RIVER LABORATORIES INC.: REVENUE SHARE, BY REGION, 2019 (%